Curcumin Suppresses Tumor Growth and Angiogenesis in Human Glioma Cells Through Modulation of Vascular Endothelial Growth Factor/ Angiopoietin-2/Thrombospondin-1 Signaling

Author(s): Zhiqiang Zhang*, Cong Li, Qijia Tan, Caijun Xie, Yanying Yang, Wengang Zhan, Fu Han, Hari Shanker Sharma*, Aruna Sharma.

Journal Name:CNS & Neurological Disorders - Drug Targets

Volume 16 , Issue 3 , 2017

Graphical Abstract:


Abstract:

Purpose: To investigate the effect of curcumin on tumor growth and angiogenesis of human gliomas and identify the underlying molecular mechanisms.

Methods: A mouse xenograft glioma model was established by subcutaneously inoculating tumor cell aggregates derived from the U87 cell line. Mice were treated with 0.01ml/g body weight of curcumin or saline. Tumor volume was measured. Microvessel density was assessed by CD34 immunostaining, and angiogenesis by immunohistochemical staining of vascular endothelial growth factor (VEGF), angiopoietin-2 (Ang-2) and thrombospondin 1 (TSP-1).

Results: At 28 days after treatment, tumor weights in the curcumin-treated group were much smaller than in the control group (0.23±0.11g vs 0.44±0.15g,p<0.05), resulting in a 45.8% inhibition of tumor growth. Curcumin also markedly inhibited microvessel density. Expression of VEGF and Ang-2 was inhibited by curcumin, whereas TSP-1 expression was up-regulated.

Conclusion: This study shows that curcumin inhibits tumor growth by inhibiting VEGF/Ang-2/TSP-1- mediated angiogenesis in a xenograft glioma mouse model.

Keywords: Curcumin, glioma, angiogenesis, vascular endothelial growth factor.Curcumin, glioma, angiogenesis, vascular endothelial growth factor.

Rights & PermissionsPrintExport

Article Details

VOLUME: 16
ISSUE: 3
Year: 2017
Page: [346 - 350]
Pages: 5
DOI: 10.2174/1871527315666160902144513
Price: $58

Article Metrics

PDF: 45
HTML: 1
EPUB: 0
PRC: 0